Trial Profile
A Phase I, First Time in Man, Single-Centre, Randomised, Double-Blind (Within Panels), Placebo-Controller Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1704 After Administration of Oral Single Ascending Doses in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2008
Price :
$35
*
At a glance
- Drugs AZD 1704 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors AstraZeneca
- 02 Jul 2008 New trial record.